Abstract
More than half of those born after 1960 will develop cancer during their lifetime. Fortunately, owing to improved diagnosis and treatment, cure rates have risen steadily over the last three decades. With an increased survivorship, more will experience adverse effects of cancer therapeutics on the heart. As the oncologist's focus begins to encompass the issues of cancer survivorship, awareness of the management of cardiac toxicity would be prudent for all physicians looking after patients with cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 3-9 |
| Journal | Ulster Medical Journal |
| Volume | 86 |
| Issue number | 1 |
| Publication status | Published - 01 Jan 2017 |
Keywords
- cardiotoxicity
- Cancer
- Survivorship
Access to Document
- Walls Cardiotoxicity Review UMJ2017
Copyright 2017 the authors. This is an open access article published under a Creative Commons Attribution-NonCommercial-ShareAlike License (https://creativecommons.org/licenses/by-nc-sa/4.0/), which permits use, distribution and reproduction for non-commercial purposes, provided the author and source are cited and new creations are licensed under the identical terms.
Fingerprint
Dive into the research topics of 'Cardiotoxicity Following Cancer Treatment.'. Together they form a unique fingerprint.Student theses
-
Biophysical correlates of base-mediated radiation cardiotoxicity in non-small cell lung cancer
Author: Walls, G., Jul 2023Supervisor: Butterworth, K. (Supervisor), Jain, S. (Supervisor) & Cole, A. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of Philosophy